Skip to main content
. 2017 Aug 23;7:9198. doi: 10.1038/s41598-017-09740-x

Table 5.

Diagnosis of biliary tract cancer by the combination of serum MIC-1 and serum CA19-9.

Cut-off value Sensitivity (%) Specificity (%)
Serum MIC-1 4021 pg/ml 54.5 (12/22) 85.2 (23/27)
Serum CA19-9 42.4 U/ml 73.9 (17/23) 79.2 (19/24)
Combination of serum MIC-1 and CA19-9 82.6 (19/23) 72.4 (21/29)

MIC-1, macrophage inhibitory cytokine-1.